Directly targeting glycosyltransferases such as B3GNT3 in pancreatic cancer or ALG3 to induce immunogenic ferroptosis represents a promising strategy, particularly given the ability of ALG3 inhibition to enhance immunotherapy responses [41,42,59]. This evidence concerns the gene B3GNT3 and pancreatic neoplasm.